🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Sweden / NCT04934462
Recruiting Not applicable

Evaluation of Non-Surgical and Arthroscopic Treatment for Hip Microinstability

NCT04934462 · tracked via the Priya Life Science Sweden tracker
Phase
Not applicable
Started
2021-11-26
Last updated
2025-03-12

Condition(s) studied

Musculoskeletal AbnormalitiesHip Injuries

Investigational drug(s) / intervention(s)

physiotherapyarthroscopy

physiotherapy: Six months physiotherapy aimed at hip stability.

arthroscopy: Arthroscopic plication of hip joint capsule.

Study summary

Microinstability of the hip joint is an important cause of hip pain and reduced hip function in young and active individuals. Hip microinstability is due to extraphysiologic hip motion and could be secondary to acetabular dysplasia, connective tissue disorder, macrotrauma, microtrauma, iatrogenic- and idiopathic causes. Treatment for hip microinstability is initiated with non-surgical treatment consisting of physiotherapy aimed mainly at stability. If non-surgical treatment fails, surgery with arthroscopic plication of the hip joint capsule is the preferred method. This study evaluates non-surgical and arthroscopic treatment for hip microinstability regarding hip function and adverse events.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Hip microinstability * Minimum 18 years old Exclusion Criteria: * Hip osteoarthritis * Severe hip dysplasia * Perthes disease or avascular necrosis of the femoral head * Previous surgery to the hip joint

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
GHP Ortho Center Göteborg Gothenburg Sweden Not Yet Recruiting
University of Gothenburg Gothenburg Sweden Recruiting
Capio Artro Clinic Stockholm Sweden Not Yet Recruiting

More Göteborg University trials in Sweden

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04934462 on ClinicalTrials.gov ↗ ← All trials in Sweden